Ranibizumab Injection for Macular Degeneration
Wet macular degeneration is a serious eye condition associated with aging. The most commonly used treatments for this condition include things like:
- Photodynamic therapy
- Laser surgery
Ranibizumab (Lucentis®) is one of the injections used for wet macular degeneration. It is injected directly into the affected eye once a month.
In clinical studies, ranibizumab injections were compared to placebo injections (injections without any active ingredient) or to a certain type of photodynamic therapy (PDT) commonly used to treat the condition. Ranibizumab was shown to be significantly more effective than placebo injections or PDT. In fact, up to 40 percent of those receiving injections for a year had significant vision improvement, compared to just 5 percent for placebo and 6 percent for PDT.
(Click What Is Ranibizumab Used For? to learn more. This article takes a closer look at using this drug for macular degeneration and also describes the other eye conditions it is approved to treat.)